Patents Assigned to Merck Patent GmbH
  • Patent number: 7183277
    Abstract: Novel compounds of the formula I in which D, W, X, Y, T and R1 are as defined in Patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: February 27, 2007
    Assignee: Merck Patent GmbH
    Inventors: Dieter Dorsch, Werner Mederski, Johannes Gleitz, Bertram Cezanne, Christos Tsaklakidis, Christopher Barnes
  • Patent number: 7183397
    Abstract: Nkx2-C4 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Nkx2-C4 polypeptides and polynucleotides in diagnostic assays.
    Type: Grant
    Filed: April 11, 2001
    Date of Patent: February 27, 2007
    Assignee: Merck Patent GmbH
    Inventor: Claudia Wilm
  • Patent number: 7179511
    Abstract: The invention relates to liquid-crystalline phenol esters of the formula I in which R, A1, Z1, m, L and Y are as defined in Claim 1, to liquid-crystalline media comprising at least one phenol ester of the formula I, and to electro-optical displays containing such a liquid-crystalline medium.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: February 20, 2007
    Assignee: Merck Patent GmbH
    Inventors: Volker Reiffenrath, Michael Heckmeier, Eike Poetsch, Joachim Krause, Werner Binder, Brigitte Schuler, Achim Götz
  • Patent number: 7179915
    Abstract: The present invention describes a process for preparing highly pure tris-ortho-metalled organoiridium compounds and pure organometallic compounds of this type, especially compounds of the d8 metals, which may find use as coloring components in the near future as active components (=functional materials) in a series of different types of application which can be classed within the electronics industry in its broadest sense.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: February 20, 2007
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stössel, Ingrid Bach, Hubert Spreitzer, Heinrich Becker
  • Patent number: 7179925
    Abstract: The present invention relates to a process for the reduction of aliphatic, aromatic or heterocyclic organic compounds by means of hydrides and/or derivatives thereof.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: February 20, 2007
    Assignee: Merck Patent GmbH
    Inventors: Hanns Wurziger, Guido Pieper, Norbert Schwesinger
  • Patent number: 7176285
    Abstract: PHPIP-120 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed, also disclosed are methods for utilizing PHPIP-120 polypeptides and polynucleotides in diagnostic assays.
    Type: Grant
    Filed: January 25, 2002
    Date of Patent: February 13, 2007
    Assignee: Merck Patent GmbH
    Inventors: Bjoern Hock, Klaus Duecker, Roland Kellner
  • Patent number: 7175891
    Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds of positive dielectric anisotropy, characterized in that it comprises one or more compounds of the formula I and one or more compounds of the formula IA in which R1, R2, ring A, ring B, L1-4, Z1, Z2, X1 and X2 are as defined in claim 1.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: February 13, 2007
    Assignee: Merck Patent GmbH
    Inventors: Michael Heckmeier, Sabine Schoen, Peer Kirsch
  • Patent number: 7175890
    Abstract: The present invention relates to a method of preparing a film that includes at least one layer of anisotropic polymer material. The method can include polymerizing a mixture of a filtered polymerizable mesogenic material.
    Type: Grant
    Filed: October 25, 2004
    Date of Patent: February 13, 2007
    Assignee: Merck Patent GmbH
    Inventors: Mark Verrall, Jeremy Ward, James Hanmer, David Coates
  • Patent number: 7172803
    Abstract: The present invention relates to the laser inscription of a flexible inner support layer of a multilayered support unit, which is distinguished by the fact that the laser inscription of the inner support layer is carried out through one or more flexible outer laser-inactive support layers which are separate or can be separated from one another.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: February 6, 2007
    Assignee: Merck Patent GmbH
    Inventors: Roland Raupach, Rolf Eymann
  • Publication number: 20070022901
    Abstract: Liquid or pasty metallic printing inks which contain a mixture of at least one metal effect pigment and at least one partly optically transparent effect pigment and are used for finishing prints.
    Type: Application
    Filed: May 10, 2004
    Publication date: February 1, 2007
    Applicants: XSYS Print Solutions Deutschland GmbH, Merck Patent GmbH
    Inventors: Ulrich Kurze, Peter Schlichting, Thomas Leuschner, Uwe Baz, Burkhard Krietsch
  • Patent number: 7169222
    Abstract: Multilayer interference pigment consisting of a transparent carrier material coated with alternating layers of metal oxides of low and high refractive index, the difference in the refractive indices being at least 0.1, which is obtainable by alternate coating of the transparent carrier material with a metal oxide of high refractive index and with a metal oxide of low refractive index in a wet process by hydrolysis of the corresponding water-soluble metal compounds, separation, drying and, if desired, calcination of the resulting pigment.
    Type: Grant
    Filed: July 11, 2005
    Date of Patent: January 30, 2007
    Assignee: Merck Patent GmbH
    Inventors: Hans-Dieter Brückner, Andrea Heyland, Christoph Schmidt, Christina Schank, Claudia Seibel
  • Patent number: 7169447
    Abstract: An achromatic quarter wave film (AQWF) comprising at least one quarter wave film (QWF) and at least one half wave film (HWF), each of said QWF and HWF comprising polymerized or vitrified anisotropic material, to methods and materials for the preparation of the AQWF, its use in optical devices like compensators and liquid crystal displays, and to a liquid crystal display comprising such an AQWF.
    Type: Grant
    Filed: May 9, 2003
    Date of Patent: January 30, 2007
    Assignees: Merck Patent GmbH, LG Chemical Ltd.
    Inventors: Jeong Su Yu, Moon Soo Park, Byoung Kun Jeon, Karl Skjonnemand, Kim Slaney, Mark Verrall
  • Patent number: 7169223
    Abstract: The present invention relates to effect pigments having a color flop comprising metal oxide-coated SiO2 flakes having a uniform layer thickness, where the color flop runs through all four quadrants of the a,b color coordinate system (CIELAB L,a,b system). The present invention likewise relates to processes for the preparation of these pigments in which SiO2 flakes having a uniform layer thickness are coated with metal oxides, and to the use of these pigments in cosmetics, paints, coatings, plastics, films, in security printing, in security features in documents and identity papers, for coloring seed, for coloring foods or in medicament coatings and for the preparation of pigment compositions and dry preparations.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: January 30, 2007
    Assignee: Merck Patent GmbH
    Inventors: Gerhard Pfaff, Cornelia Foerderer, Doreen Warthe, Johann Dietz
  • Patent number: 7169448
    Abstract: The invention relates to an optical compensator for liquid crystal displays comprising at least one O plate retarder, and at least one twisted A plate retarder with a twist angle ? of more than 90°, and further relates to a liquid crystal display comprising such a compensator.
    Type: Grant
    Filed: February 17, 2005
    Date of Patent: January 30, 2007
    Assignee: Merck Patent GmbH
    Inventors: David Coates, Owain Llyr Parri, Mark Verrall, Peter Le Masurier
  • Patent number: 7169449
    Abstract: A liquid crystal display device produced through the steps of injecting a polymerizable monomer-containing liquid crystal composition between two substrates and, while applying a voltage between opposing transparent electrodes of the substrates, polymerizing the monomer, wherein the polymerizable monomer contained in the liquid crystal composition has one or more ring or condensed ring structures and functional groups bonded directly to the ring or condensed ring structure. The monomer is preferably represented by the following general formula: P1-A1-(Z1-A2)n-P2 wherein P1 and P2 are acrylates or the like, A1 and A2 are 1,4-phenylenes or the like, Z1 is —COO— or the like, and n is 0 to 2.
    Type: Grant
    Filed: October 15, 2004
    Date of Patent: January 30, 2007
    Assignees: Sharp Kabushiki Kaisha, Merck Patent GmbH
    Inventors: Yohei Nakanishi, Masakazu Shibasaki, Kazutaka Hanaoka, Yuichi Inoue, Kazuaki Tarumi, Matthias Bremer, Melanie Klasen-Memmer, Simon Greenfield, Richard Harding
  • Patent number: 7170575
    Abstract: Homeotropically oriented layers and films of liquid crystals especially on polymeric substrates. The layers and films, which also can be multi-layered films comprising a homeotropically aligned anisotropic film, are preparable by application of an orientation layer to the substrate. The orientation layer can be either an organic surfactant which is fixed in a matrix of a polymeric material or an inorganic thin layer such as aluminum or Al2O3.
    Type: Grant
    Filed: August 25, 2004
    Date of Patent: January 30, 2007
    Assignee: Merck Patent GmbH
    Inventors: David Coates, Owain Llyr Parri, Jeremy Lewis Ward, David Joicey, Keith Wilbourn, Colum Dickson, John Scott
  • Publication number: 20070021456
    Abstract: Novel compounds of formula (I) are disclosed, where R1, R1?, L, Y, m and p have the meanings given in claim 1, which are inhibitors of tyrosine kinases, in particular, TIE-2 and Raf kinases and can be used for the treatment of tumors.
    Type: Application
    Filed: July 19, 2004
    Publication date: January 25, 2007
    Applicant: MERCK PATENT GMBH
    Inventors: Francesc Mitjans, Elisabet Rosel-Vives, Jaume Adan, Marta Soler, Guenter Hoelzemann, Helene Crassier, Karl-August Ackermann, Wolfgang Staehle, Alfred Jonczyk, Wilfried Rautenberg
  • Patent number: 7166724
    Abstract: An ionic liquid of the formula K+A?, wherein K and A are as defined herein, can be used in such things as electrochemical cells, supercapacitors, hydraulic liquids, solvents, organic syntheses.
    Type: Grant
    Filed: May 30, 2001
    Date of Patent: January 23, 2007
    Assignee: Merck Patent GmbH
    Inventors: Volker Hilarius, Udo Heider, Michael Schmidt
  • Patent number: 7166701
    Abstract: Survivin Interacting Protein 1 and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing SIP-1 polypeptides and polynucleotides in diagnostic assays.
    Type: Grant
    Filed: March 21, 2001
    Date of Patent: January 23, 2007
    Assignee: Merck Patent GmbH
    Inventors: Bernd Hentsch, Klaus Dücker, Björn Hock
  • Publication number: 20070014934
    Abstract: The invention relates to novel 9- and/or 10-substituted anthracenes, to their use in liquid crystal, light-emitting or semiconducting materials and devices, in anisotropic polymers, optical, electrooptical, decorative, security, cosmetic, diagnostic, electric, electronic, charge transport, semiconductor, optical recording, electroluminescent, photoconductor or electrophotographic applications, and to liquid crystal, light-emitting and semiconducting materials, polymers and devices comprising them.
    Type: Application
    Filed: June 30, 2004
    Publication date: January 18, 2007
    Applicant: MERCK PATENT GMBH
    Inventors: Mark Goulding, Marcus Thompson, Warren Duffy, Martin Heeney, Iain McCulloch